{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:42:53Z","timestamp":1707525773875},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,23]]},"DOI":"10.7759\/cureus.52817","type":"journal-article","created":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T01:15:36Z","timestamp":1706058936000},"source":"Crossref","is-referenced-by-count":0,"title":["Pattern and Predictors of Infection Among Patients With Rheumatological Disease on Immunosuppressive Medications: A Retrospective Study in a Tertiary Care Hospital in Bangladesh"],"prefix":"10.7759","author":[{"given":"S.K. Jakaria","family":"Been Sayeed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md","family":"Moniruzzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A K M Humayon","family":"Kabir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md Uzzwal","family":"Mallik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bikas","family":"Chandra Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahin","family":"Mahmud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahim T","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrin","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Mujibur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-999-0013-5","article-title":"Biologic therapies in rheumatoid arthritis","volume":"1","author":"Bulpitt KJ","year":"1999","unstructured":"Bulpitt KJ. Biologic therapies in rheumatoid arthritis. Curr Rheumatol Rep. 1999, 1:157-63. 10.1007\/s11926-999-0013-5","journal-title":"Curr Rheumatol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2018.09.003","article-title":"Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data","volume":"15","author":"Quartuccio L","year":"2019","unstructured":"Quartuccio L, Zabotti A, Del Zotto S, Zanier L, De Vita S, Valent F. Risk of serious infection among patients receiving biologics for chronic inflammatory diseases: usefulness of administrative data. J Adv Res. 2019, 15:87-93. 10.1016\/j.jare.2018.09.003","journal-title":"J Adv Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61704-9","article-title":"Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"386","author":"Singh JA","year":"2015","unstructured":"Singh JA, Cameron C, Noorbaloochi S, et al.. Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015, 386:258-65. 10.1016\/S0140-6736(14)61704-9","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu185","article-title":"Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis","volume":"58","author":"Kourbeti IS","year":"2014","unstructured":"Kourbeti IS, Ziakas PD, Mylonakis E. Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clin Infect Dis. 2014, 58:1649-57. 10.1093\/cid\/ciu185","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2020-001235","article-title":"Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis","volume":"7","author":"Riley TR","year":"2021","unstructured":"Riley TR, George MD. Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis. RMD Open. 2021, 7:10.1136\/rmdopen-2020-001235","journal-title":"RMD Open"},{"key":"ref6","article-title":"Infection in systemic lupus erythematosus patients","volume":"43","author":"Dorgham DA","year":"2021","unstructured":"Dorgham DA, Anwar S, Khaled AS. Infection in systemic lupus erythematosus patients. Egypt Rheumatol. 2021, 43:115-8.","journal-title":"Egypt Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-77","article-title":"Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-\u03b1 antagonists","volume":"12","author":"Germano V","year":"2014","unstructured":"Germano V, Cattaruzza MS, Osborn J, Tarantino A, Di Rosa R, Salemi S, D'Amelio R. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-\u03b1 antagonists. J Transl Med. 2014, 12:77. 10.1186\/1479-5876-12-77","journal-title":"J Transl Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.41456","article-title":"COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes","volume":"72","author":"Haberman RH","year":"2020","unstructured":"Haberman RH, Castillo R, Chen A, et al.. COVID-19 in patients with inflammatory arthritis: a prospective study on the effects of comorbidities and disease-modifying antirheumatic drugs on clinical outcomes. Arthritis Rheumatol. 2020, 72:1981-9. 10.1002\/art.41456","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson EJ","year":"2020","unstructured":"Williamson EJ, Walker AJ, Bhaskaran K, et al.. Factors associated with COVID-19-related death using OpenSAFELY. Nature. 2020, 584:430-6. 10.1038\/s41586-020-2521-4","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200507","article-title":"Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis","volume":"47","author":"Favalli EG","year":"2020","unstructured":"Favalli EG, Agape E, Caporali R. Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis. J Rheumatol. 2020, 47:1296. 10.3899\/jrheum.200507","journal-title":"J Rheumatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217763","article-title":"Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases","volume":"79","author":"Pablos JL","year":"2020","unstructured":"Pablos JL, Abasolo L, Alvaro-Gracia JM, et al.. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases. Ann Rheum Dis. 2020, 79:1170-3. 10.1136\/annrheumdis-2020-217763","journal-title":"Ann Rheum Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco M","year":"2020","unstructured":"Gianfrancesco M, Hyrich KL, Al-Adely S, et al.. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020, 79:859-66. 10.1136\/annrheumdis-2020-217871","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200702","article-title":"Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis","volume":"71","author":"Dixon WG","year":"2012","unstructured":"Dixon WG, Abrahamowicz M, Beauchamp ME, Ray DW, Bernatsky S, Suissa S, Sylvestre MP. Immediate and delayed impact of oral glucocorticoid therapy on risk of serious infection in older patients with rheumatoid arthritis: a nested case-control analysis. Ann Rheum Dis. 2012, 71:1128-33. 10.1136\/annrheumdis-2011-200702","journal-title":"Ann Rheum Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23611","article-title":"Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis","volume":"71","author":"Wilson JC","year":"2019","unstructured":"Wilson JC, Sarsour K, Gale S, Peth\u00f6-Schramm A, Jick SS, Meier CR. Incidence and risk of glucocorticoid-associated adverse effects in patients with rheumatoid arthritis. Arthritis Care Res (Hoboken). 2019, 71:498-511. 10.1002\/acr.23611","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000957","article-title":"Methotrexate for rheumatoid arthritis","author":"Suarez-Almazor ME","year":"2000","unstructured":"Suarez-Almazor ME, Belseck E, Shea B, Wells G, Tugwell P. Methotrexate for rheumatoid arthritis. Cochrane Database Syst Rev. 2000, CD000957. 10.1002\/14651858.CD000957","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010015","article-title":"Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis","volume":"8","author":"Ibrahim A","year":"2018","unstructured":"Ibrahim A, Ahmed M, Conway R, Carey JJ. Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis. J Clin Med. 2018, 8:10.3390\/jcm8010015","journal-title":"J Clin Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/art.10529","article-title":"Predictors of infection in rheumatoid arthritis","volume":"46","author":"Doran MF","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O'Fallon WM, Gabriel SE. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 2002, 46:2294-300. 10.1002\/art.10529","journal-title":"Arthritis Rheum"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146351","article-title":"Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis","volume":"11","author":"Lin J","year":"2016","unstructured":"Lin J, Liu J, Davies ML, Chen W. Serum vitamin D level and rheumatoid arthritis disease activity: review and meta-analysis. PLoS One. 2016, 11:e0146351. 10.1371\/journal.pone.0146351","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-014-0755-z","article-title":"Inflammation and vitamin D: the infection connection","volume":"63","author":"Mangin M","year":"2014","unstructured":"Mangin M, Sinha R, Fincher K. Inflammation and vitamin D: the infection connection. Inflamm Res. 2014, 63:803-19. 10.1007\/s00011-014-0755-z","journal-title":"Inflamm Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094496","article-title":"Hypoalbuminemia as surrogate and culprit of infections","volume":"22","author":"Wiedermann CJ","year":"2021","unstructured":"Wiedermann CJ. Hypoalbuminemia as surrogate and culprit of infections. Int J Mol Sci. 2021, 22:10.3390\/ijms22094496","journal-title":"Int J Mol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/0005117","article-title":"Hematological manifestations among patients with rheumatic diseases","volume":"144","author":"Klein A","year":"2021","unstructured":"Klein A, Molad Y. Hematological manifestations among patients with rheumatic diseases. Acta Haematol. 2021, 144:403-12. 10.1159\/0005117","journal-title":"Acta Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207673-pattern-and-predictors-of-infection-among-patients-with-rheumatological-disease-on-immunosuppressive-medications-a-retrospective-study-in-a-tertiary-care-hospital-in-bangladesh","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:12:52Z","timestamp":1707509572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207673-pattern-and-predictors-of-infection-among-patients-with-rheumatological-disease-on-immunosuppressive-medications-a-retrospective-study-in-a-tertiary-care-hospital-in-bangladesh"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,23]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.52817","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,23]]}}}